What life sciences contract manufacturers must do now to stay competitive tomorrow
With the global CDMO sector on track for continued growth and complexity in 2025, only the most agile and tech-enabled manufacturers will thrive. This industry brief highlights the top trends shaping contract manufacturing in life sciences – and what leading CMOs/CDMOs are doing to stay ahead.
Key trends shaping 2025:
Digital transformation
• 60 per cent of executives plan to increase AI investments
• Digital tools reduce documentation time by up to 30 per cent
• Predictive maintenance, digital twins and real-time quality control are driving efficiency and uptime
Flexibility meets personalisation
• Surge in demand for cell and gene therapies and drug-device combos
• Requires agile, multi-modal facilities and rapid changeovers
• Collaboration and process standardisation now key to scalability
Regulatory and sustainability evolution
• Regulatory changes (such as EU Annex 1) demand digital readiness
• Environmental performance now part of compliance
• Manufacturers must align with eco-friendly practices and supplier codes of conduct
© 2025, Lyonsdown Limited. Business Reporter® is a registered trademark of Lyonsdown Ltd. VAT registration number: 830519543